Eric Francois, MD, on Rectal Cancer: Findings From the ACCORD12 Trial (French Language Version)

2016 Gastrointestinal Cancers Symposium
Tweet this page

Eric Francois, MD, of the Centre Antoine-Lacassagne, discusses in French the 5-year follow-up results from this phase III study of neoadjuvant treatment in rectal cancer (Abstract 490).

Advertisement

Advertisement



Advertisement